Recce Pharmaceuticals (ASX:RCE) Achieves Phase II Trial Milestone
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.
Category: Healthcare
Wellnex Life Limited (ASX:WNX) Announces Pain Away Update
Wellnex Life (ASX:WNX) updates on Pain Away acquisition funding and future dual listing plans.
Liontown Resources (ASX:LTR) Delivers Strong December Quarter Results
Liontown Resources (ASX:LTR) reports strong production and financial performance for the December quarter, achieving positive cash flow.
Hazer Group Limited (ASX:HZR) Reports Successful Q4 Activities
Hazer Group Limited reports significant operational milestones and financial strength in its Q4 2024 update.
BHP Group Limited (ASX:BHP) Operational Review for Half Year 2024
BHP reports a significant operational performance increase with a 10% rise in copper production and strategic developments for future growth.
Alkane Resources Ltd (ASX:ALK) Announces Significant Gold Intercepts
Alkane Resources Ltd announces significant gold intercepts at Tomingley, enhancing exploration potential.
Agrimin Limited (ASX:AMN) Secures Environmental Approval for Mackay Potash Project
Agrimin Limited has secured Western Australian environmental approval for its Mackay Potash Project, advancing its development plans.
Genetic Technologies Limited (ASX:GTG) Sells Affinity and EasyDNA Businesses
Genetic Technologies Limited (ASX:GTG) completes the sale of AffinityDNA and EasyDNA businesses to Endeavor DNA, Inc., streamlining operations amid administration.
333D Limited (ASX:T3D) Reports Quarterly Cash Flow and Activities
333D Limited (ASX:T3D) reports a 31% increase in cash receipts and highlights significant contract revenue in its quarterly results.
Element 25 Limited (ASX:E25) Secures $166M Grant for Manganese Project
Element 25 Limited secures a US$166 million grant to support its high-purity manganese project in Louisiana, promising significant local economic benefits.